Teva Is the 23rd Drug Maker to Impose Limits on 340B Contract Pharmacies - 340B Report
Teva Launches New “Pivot to Growth” Strategy | Business Wire
Teva CEO stands down during troubled times - MedCity News
Teva Stock Dives After Inking $1.5 Billion Deal For Inflammation Drug | Investor's Business Daily
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
Teva pharmaceutical industries hi-res stock photography and images - Alamy
Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO | BioSpace
Teva Pharmaceutical to Cut 14,000 Jobs - WSJ
Watch CNBC's full interview with Teva CEO Richard Francis - YouTube
Buyers remorse or fraud? Teva and Mexican brothers slug it out over sour deal
DOJ orders Teva and Glenmark to pay millions in fines in drug price fixing settlment
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva Pharmaceuticals Q4 2016 Earnings
Teva to Pay a $225 Million Settlement for Cholesterol Drug Price-Fixing Charges - news.law
Teva boss hits out at opioid lawsuits
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
teva News and latest stories | The Jerusalem Post
Eagle Pharma, Teva Pharma Diverge On 'Surprise' Leukemia Drug Win | Stock News & Stock Market Analysis - IBD
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges - WSJ
Teva says Israel-Hamas war not hurting production, eyes growth in 2024 | Reuters
Teva quits brand lobby PhRMA, in line to lead generic lobby AAM - STAT
Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva Pharmaceutical Sets Aside $200 Million for Potential DOJ Settlement - Bloomberg
